News

22nd Jul 2009 - Patent granted by the OAPI

A patent for ’The Treatment of HIV’ has been added to the AIMSPRO IP portfolio, having an effective date of 31st March 2009. The patent has been granted by the African Intellectual Property Organisation (O.A.P.I. – Organisation Africaine de la Propriété Intellectuelle) and it covers the African states of Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Republic of Congo, Cote d'Ivoire, Equatorial Guinea, Gabon, Guinea, Guinea Bissau, Mali, Mauritania, Niger, Senegal and Togo. The grant of this single patent is valid in all these countries.

Daval Chairman Brian Quick will now oversee the process by which assessment of AIMSPRO as a potential anti-viral agent will proceed.